Cubist Systematic Strategies, LLC Pro Qr Therapeutics N.V. Transaction History
Cubist Systematic Strategies, LLC
- $20.3 Billion
- Q2 2025
A detailed history of Cubist Systematic Strategies, LLC transactions in Pro Qr Therapeutics N.V. stock. As of the latest transaction made, Cubist Systematic Strategies, LLC holds 4,061 shares of PRQR stock, worth $11,939. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,061
Previous 89,645
95.47%
Holding current value
$11,939
Previous $119,000
93.28%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding PRQR
# of Institutions
64Shares Held
41.2MCall Options Held
26KPut Options Held
0-
Adage Capital Partners Gp, L.L.C. Boston, MA6.6MShares$19.4 Million0.02% of portfolio
-
Privium Fund Management B.V.5MShares$14.7 Million2.17% of portfolio
-
Affinity Asset Advisors, LLC New York, NY3.5MShares$10.3 Million1.2% of portfolio
-
Morgan Stanley New York, NY3.08MShares$9.07 Million0.0% of portfolio
-
Sio Capital Management, LLC New York, NY2.08MShares$6.1 Million2.02% of portfolio
About ProQR Therapeutics N.V.
- Ticker PRQR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,362,096
- Market Cap $210M
- Description
- ProQR Therapeutics N.V., a biopharmaceutical company, engages in the discovery and development of RNA-based therapeutics for the treatment of genetic disorders. It primarily develops sepofarsen that is in phase II/III clinical trial illuminate trial for treating leber congenital amaurosis 10 disease; and ultevursen, which is in phase II/III clin...